The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

CamDiab announced today that it is introducing CamAPS Liberty, a fully closed-loop feature for its CamAPS FX app.

Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 ...

As demand grows for reliable positioning beyond conventional Global Navigation Satellite Systems (GNSS), researchers are turning to Low Earth Orbit ...

Most of us spent years worrying about plagiarism, citation errors, and the occasional ghostwriter. Suddenly, in what felt like an instant, generative AI ...

Findings highlight users’ active feedback, reporting and engagement can influence algorithms and reshape digital content ...

👉 Learn how to divide polynomials by quadratic divisors using the long division algorithm. Before dividing a polynomial, it ...

Digital dopamine loops are changing how Gen Z interacts with social media. Learn how constant scrolling, likes, and ...

Karpathy's 'autoresearch' agent did not improve its own code, but it points towards systems that could as well as towards way ...

The new architecture shows how quantum processors could work alongside classical HPC, creating hybrid environments to tackle ...

Brands that run headfirst into AI-driven processes may be accidentally automating away their most valuable asset: credibility ...